Squarepoint’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$529K Sell
23,026
-46,744
-67% -$1.07M ﹤0.01% 1875
2025
Q1
$2.02M Buy
69,770
+52,106
+295% +$1.51M ﹤0.01% 1156
2024
Q4
$656K Buy
17,664
+11,929
+208% +$443K ﹤0.01% 1788
2024
Q3
$278K Sell
5,735
-84,817
-94% -$4.12M ﹤0.01% 2041
2024
Q2
$3.62M Buy
90,552
+8,501
+10% +$340K 0.01% 801
2024
Q1
$3.6M Sell
82,051
-1,393
-2% -$61.2K 0.01% 824
2023
Q4
$5.16M Sell
83,444
-18,058
-18% -$1.12M 0.01% 667
2023
Q3
$4.67M Buy
101,502
+31,874
+46% +$1.47M 0.01% 631
2023
Q2
$4M Buy
69,628
+58,372
+519% +$3.35M 0.01% 632
2023
Q1
$422K Sell
11,256
-4,197
-27% -$157K ﹤0.01% 1541
2022
Q4
$433K Buy
+15,453
New +$433K ﹤0.01% 1519
2022
Q2
Sell
-30,634
Closed -$1.1M 2100
2022
Q1
$1.1M Buy
+30,634
New +$1.1M ﹤0.01% 1103
2021
Q3
Sell
-40,760
Closed -$822K 2205
2021
Q2
$822K Buy
+40,760
New +$822K ﹤0.01% 1309
2021
Q1
Sell
-10,714
Closed -$215K 2525
2020
Q4
$215K Sell
10,714
-7,921
-43% -$159K ﹤0.01% 2084
2020
Q3
$349K Sell
18,635
-56,553
-75% -$1.06M ﹤0.01% 1581
2020
Q2
$1.69M Buy
75,188
+46,550
+163% +$1.05M 0.03% 683
2020
Q1
$425K Sell
28,638
-73,001
-72% -$1.08M 0.01% 1120
2019
Q4
$1.96M Buy
101,639
+52,696
+108% +$1.02M 0.01% 894
2019
Q3
$971K Sell
48,943
-5,880
-11% -$117K 0.01% 1227
2019
Q2
$1.16M Buy
54,823
+33,161
+153% +$700K 0.01% 1164
2019
Q1
$443K Sell
21,662
-9,110
-30% -$186K ﹤0.01% 1526
2018
Q4
$612K Buy
+30,772
New +$612K 0.01% 1136
2018
Q2
Sell
-18,018
Closed -$338K 1727
2018
Q1
$338K Buy
+18,018
New +$338K 0.01% 1260
2016
Q4
Sell
-14,049
Closed -$267K 1746
2016
Q3
$267K Buy
+14,049
New +$267K 0.02% 781